Cystic fibrosis: cost of illness and considerations for the economic evaluation of potential therapies.
D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D017281:Cost of Illness; D003550:Cystic Fibrosis / Q000191:economics* / Q000453:epidemiology / Q000628:therapy; D003850:Deoxyribonuclease I / Q000191:economics / Q000627:therapeutic use; D017048:Health Care Costs; D006699:Home Care Services / Q000191:economics; D006760:Hospitalization / Q000191:economics; D006801:Humans; D007275:Injections, Intravenous; D011788:Quality of Life
D000890:Anti-Infective Agents; C085693:DNASE1 protein, human; D003850:Deoxyribonuclease I